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Abstract
Background: Due to the increasing rate of hospital-acquired infections, it is essential to select appropriate
disinfectant agents. In this study, the efficacy of hospital disinfectants against nosocomial infection pathogens was
compared.
Methods: High level disinfectants (Steranios 2%, Deconex HLDPA, and Microzed Quatenol) were tested for their
antibacterial effects by determining their minimum inhibitory (MIC) and minimum bactericidal concentrations (MBC)
against Enterococcus faecalis ATCC 29212 and Burkholderia cepacia ATCC 10673.
Results: E. faecalis, as gram-positive bacterium, was more susceptible to high level disinfectants compared to gram-
negative B.cepacia. The MIC =MBC values of 2% Steranios, Deconex HLDPA and Microzed Quatenol against E.
faecalis and B.cepacia were 0.31, 9.77, 2.2 mg/L and 9.8, 78.13, 70.31 mg/L, respectively.
Conclusions: According to the findings of this study, the most effective disinfectants against both E. faecalis and
B.cepacia were Steranios 2%, Microzed Quatenol, and Deconex HLDPA in order. Considering the importance of
these bacterial strains in healthcare-associated infections, the use of these effective disinfectants is recommended in
the hospitals.
Keywords: Health care associated infections, nosocomial infection pathogens, High level disinfectants, Minimum
inhibitory concentration (MIC), Enterococcus faecalis ATCC 29212, Burkholderia cepacia ATCC 10673
Introduction
Healthcare-associated infections with approximately 7.1
million annual cases and 99,000 annual deaths in the
United States have been recognized as a group of im-
portant causes of morbidity and mortality in admitted
patients [1]. The patient’s microbiota is believed to be
the major source of infections that are transmitted from
the medical staff and the hospital environment.
Approximately 20–40% of these infections are transmit-
ted via hands [2, 3]. Hospital-acquired infections are a
major concern in health care centers, which may also in-
crease the length of hospitalization, costs and mortality
rate in patients [4]. Contamination of the hospital envir-
onment plays a significant role in the transmission of
several pathogens such as Methicillin-resistant Staphylo-
coccus aureus (MRSA) and Vancomycin-resistant En-
terococcus (VRE) [4, 5]. Another bacterial species that
has been important in recent years as a multi-drug re-
sistance agent of hospital infections is Burkholderia
cepacia, which was first described in patients with sys-
temic fibrosis in the late 1970s. Burkholderia cepacia
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isolates are usually resistant to various classes of antibi-
otics and disinfectants [6]. Enterococci have been long
recognized as important human pathogens and Entero-
coccus faecalis is one of the most common and life-
threatening causes of nosocomial infections [7, 8]. In the
healthcare setting Enterococcus faecalis was known as an
important cause of hospital-acquired bacteremia and
mortality among the elderly and patients with major dis-
order conditions [9].
To prevent infections, it is important to remove
bacterial biofilms from contaminated surfaces equip-
ment and the medical environment [10]. Contami-
nated hospital surfaces can transmit the pathogens to
the patients, so cleaning and disinfecting surfaces will
break this chain [1]. Decontamination methods such
as sterilization (physical or chemical) and disinfec-
tion processes are key principles of successful pro-
grams in the control of nosocomial infections [6].
Persistence of hospital infections may be in part due
to the inappropriate and inadequate use of decontam-
ination methods [11]. In hospitals, medical instru-
ments are classified into three categories of critical,
semi-critical, and non-critical based on the risk of in-
fection transmission and contact with the patient’s
body. Critical items enter sterile tissues so the use of
these devices increases the risk of infection if they are
not properly disinfected; therefore, in these cases ap-
plying liquid chemical disinfectants is essential after
reuse [7, 12]. The main purpose of using disinfectants
in hospitals is to reduce the risk of sporadic and epi-
demic infections. To achieve this goal, different
methods and various disinfectants are recommended
[13, 14]. Furthermore, due to the changing patterns
of resistance in nosocomial pathogens, daily revision
of the efficacy of disinfectants and chemical sterilizers
against multi-drug resistant pathogens seems neces-
sary [15].
However, due to the accessibility of various and
different brands of disinfectant products, selection of
the right one has become a challenge for environ-
mental health experts and infection control supervi-
sors in the health-care settings. The choice of
disinfectants according to the manufacturer’s instruc-
tions is not only unreliable but also causes irrevers-
ible damages to instruments and increases the rate
of outbreaks related to the disinfectant-resistant
pathogens in hospitals in some cases. As an environ-
mental health expert working in a hospital, i have an
unpleasant experience in this field because one of
our endoscopic devices was seriously damaged after
a few months of using the peroxyacetic acid (PAA)
solution.
Therefore, it is necessary to investigate the sensitivity
of bacterial pathogens to currently used disinfectants by
different methods such as determining the minimum in-
hibitory concentration (MIC) and minimum bactericidal
concentration (MBC). The aim of the present study was
to determine the efficacy of high level disinfectants
against two multidrug resistant bacterial pathogens, E.
faecalis (ATCC 29212) and B. cepacia (ATCC 10673),
by determining the MIC and MBC of each disinfectant
and comparing their efficacy with on another.
Methods
Materials
This experimental study was conducted in the Diagnos-
tic Microbiology Lab of Imam Khomeini Hospital,
Urmia, Iran in 2017. Mueller-Hinton agar (MHA),
Mueller-Hinton broth (MHB), and skim milk containing
15% sterile glycerol (all purchased from Merck,
Germany) were used for cultivation the bacteria, deter-
mining the MICs and MBCs, and storing the isolates. B.
cepacia ATCC 10673 and E. faecalis ATCC 29212 were
obtained from Iranian Biological Resource Center
(IBRC) and Persian Type Culture Collection (PTCC) re-
spectively and stored in skim milk containing 15% gly-
cerol at − 20 °C. Three disinfectants including Deconex
HLDPA (DH), Steranios 2%, and Microzed Quatenol
(MQ) were obtained from Armanbehboud, Ayriaborna,
and Pharmedparto Company, respectively. These disin-
fectants are applied routinely as liquid chemical sterility
agents in operation rooms and bronchoscopy and endos-
copy units in our hospital. The basic compounds of each
disinfectant are shown in Table 1.
Preparation of serial dilutions of disinfectants
Briefly, serial two-fold dilutions of disinfectants were
prepared in sterile MHB. To prepare various concentra-
tions of disinfectants, 27 sterile test tubes were num-
bered from 1 to 27 (As shown in Fig. 1). One mL of
sterile MHB was added to each tube in aseptic condi-
tions. One mL of testing disinfectant (undiluted) was
poured into the tube No. 1; after mixing, serial two-fold
dilutions were prepared by adding 1 mL of the contents
of each tube to the next one. The process continued to
the tube 25 (except for tubes 26 and 27). From tube 25,
one milliliter was poured out, so the volume of all tubes
was adjusted to 1 mL. Tubes 26 and 27 were considered
Table 1 Basic compounds of tested antimicrobial agents
Brand of biocidal agents DH 2% Steranios MQ
Basic compounds biocidal
agents




Alcohol based with three types
of quaternary ammonium compounds
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as negative (disinfectant + MHB) and positive (1.5 × 106
CFU of bacterial inoculums + MHB) controls, respect-
ively. This procedure was done for all disinfectants. All
experiments were done in triplicates for each tested dis-
infectant and each bacterial strain.
Preparation of the McFarland turbidity standards
McFarland turbidity standards were prepared as refer-
ences for estimating the amount of bacterial inoculum.
In this study, 0.5 McFarland turbidity standard was pre-
pared [16] by adding 0.5 mL of 0.048M barium chloride
(1.17% w/v BaCl2. 2H2O) solution to 99.5 mL of 0.18
H2SO4 (1% v/v) and mixing with a magnetic stirrer. To
compare the 0.5 McFarland turbidity standards with
bacterial suspension, about 10 mL of this standard was
transferred to a glass capped tube. The prepared solution
should not be frozen and can be kept for up to 6
months. Vertex should always be applied before the use
of turbidity standards and the standard cannot be used if
rust or color change is observed or after the expiration
date.
Bacteria suspension
The 0.5 McFarland standard [17] was used as a reference
to compare the turbidity of bacterial inoculum in order
to adjust the approximate cell density. Fresh cultures of
bacterial strains were prepared on the MHA medium by
overnight incubation at 37 °C. Then, 3–4 colonies of
each bacterial strain were picked up with a sterile cotton
swab and transferred to 4–5 ml of sterile buffered saline.
After mixing perfectly, turbidity was visually compared
with the 0.5 McFarland standard. After adjustment, the
bacterial amount in the broth culture was approximately
1.5 × 108 colony-forming units per mL (CFU/mL).
Determination of MIC and MBC
The susceptibility of the bacterial strains was deter-
mined using the modified microdilution method rec-
ommended by NCCLS (National Committee for
Clinical Laboratory Standards) guidelines [17]. MIC24
is defined as the lowest concentration of a biocide
agent which has an inhibitory effect on the cultivated
bacterium, causing no turbidity in the test tube after
incubation at 37 °C for 24 h. After preparing serial
dilutions, 10 μl (1.5 × 106 CFU/mL) of 0.5 McFarland
adjusted fresh bacterial culture was inoculated to each
dilution and tubes were incubated at 37 °C for 24 h.
Then, the test tubes were examined for their turbid-
ity. The lowest concentration of a disinfectant that
inhibited the bacterial visible growth was considered
as MIC. To determine the minimum bactericidal
concentration of disinfectants, 5 μl of each tube was
sub-cultured on the surface of MHA at 37 °C for 24 h
and then colony count was done. MBC24 was consid-
ered as the concentration of the disinfectant that pre-
vented the growth of 99.9% (3-log) of the bacteria as
growing less than 15 colonies on MHA.
Results
The values of MIC24 & MBC24 for the tested disinfec-
tants were as follows:
Steranios 2%
In our hospital Steranios 2% containing 2% glutaralde-
hyde is commonly used as a disinfectant or sterilizer for
critical and semi-critical items in an exposure time and
concentration dependent manner. It is available in both
forms of liquid or gas, but the liquid form is used in our
hospital. The MIC and the MBC of Steranios 2% for E.
faecalis ATCC 29212 was 0.31 mg/L. At sub-MIC doses
with a lower concentration of the biocide, the tubes were
turbid and the bacteria grew easily after cultivating on
solid media. The MIC and the MBC of Steranios 2% for
B. cepacia ATCC 10673 was 9.83 mg/L (Table 2).
Deconex HLDPA (DH)
DH is applied as a high-level disinfectant to sterilize re-
usable medical devices such as flexible endoscopes in
Fig. 1 Broth Dilution Method for determining MIC and MBC values of disinfectants against tested bacteria. MIC is equal to MBC = 312mg/L. The
Mueller-Hinton broth (MHA) and Mueller-Hinton agar were used for determining MIC and MBC, respectively. The inoculum size was 1.5 × 106 CFU/mL
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operating rooms and intensive care units. As shown in
Table 2, The MIC and the MBC of DH for E. faecalis
ATCC 29212 and B. cepacia ATCC 10673 was 9.77mg/L
and 78.13mg/L, respectively.
Microzed Quatenol (MQ)
MQ antimicrobial agents are ready-to-use disinfectants
in hospitals, clinics, and dental settings that are applied
in the form of spray on sensitive surfaces of electronic
equipment, cameras, work tables and dental units in
health-care centers. As shown in Table 1, in order to in-
crease the efficacy, MQ contains alcohol and three types
of quaternary ammonium compounds. The MIC and the
MBC values of MQ for E. faecalis ATCC 29212 and B.
cepacia ATCC 10673 were 2.2 mg/L and 70.31 mg/L, re-
spectively. The MBC values for both strains were equal
to MIC values. According to Table 3, the concentration
ranges for Steranios 2%, DH, and MQ were 5035–
0.0003, 5000–0.0003, and 4500.0–0.0003 mg/L,
Table 2 MIC24 and MBC24 values of investigated disinfectants
for B. cepacia ATCC 10673 and E. faecalis ATCC 29212
MIC24 and MBC24 (mg/L)










E.faecalis ATCC 29212 0.31 9.77 2.2
Table 3 Concentration ranges and breakpoints of disinfectants used to determine the MIC24 and MBC24 values for B. cepacia ATCC
10673 and E. faecalis ATCC 29212
Tube
NO
MIC24 =MBC24 (mg/L) MIC24 =MBC24 (mg/L)
E. faecalis ATCC 29212 B. cepacia ATCC 10673
2% Steranios DH MQ 2% Steranios DH MQ
1 5035.00 5000.00 4500.00 5035.00 5000.00 4500.00
2 2517.50 2500.00 2250.00 2517.50 2500.00 2250.00
3 1258.75 1250.00 1125.00 1258.75 1250.00 1125.00
4 629.38 625.00 562.50 629.38 625.00 562.50
5 314.69 312.50 281.25 314.69 312.50 281.25
6 157.34 156.25 140.63 157.34 156.25 140.63
7 78.67 78.13 70.31 78.67 MIC =MBC = 78.13 MIC = MBC = 70.31
8 39.34 39.06 35.16 39.34 39.06 TO* 35.16 TO*
9 19.67 19.53 17.58 19.67 19.53 17.58
10 9.83 MIC =MBC = 9.77 8.79 MIC =MBC = 9.83 9.77 8.79
11 4.92 4.88 TO* 4.39 4.92 TO* 4.88 4.39
12 2.46 2.44 MIC = MBC = 2.20 2.46 2.44 2.20
13 1.23 1.22 1.10 TO* 1.23 1.22 1.10
14 0.61 0.61 0.55 0.61 0.61 0.55
15 MIC =MBC = 0.31 0.31 0.27 0.31 0.31 0.27
16 0.15 TO* 0.15 0.14 0.15 0.15 0.14
17 0.08 0.08 0.07 0.08 0.08 0.07
18 0.04 0.04 0.03 0.04 0.04 0.03
19 0.02 0.02 0.02 0.02 0.02 0.02
20 0.0096 0.0095 0.0086 0.0096 0.0095 0.0086
12 0.0048 0.0048 0.0043 0.0048 0.0048 0.0043
22 0.0024 0.0024 0.0021 0.0024 0.0024 0.0021
23 0.0012 0.0012 0.0011 0.0012 0.0012 0.0011
24 0.0006 0.0006 0.0005 0.0006 0.0006 0.0005
25 0.0003 0.0003 0.0003 0.0003 0.0003 0.0003
26 Negative controls (disinfectant + MHB)
27 Positive (inoculum + MHB)
*TO Turbidity was observed
*At this concentration and lower (Up to tube number 25) turbidity was observed and indicates a non-bactericidal range of disinfectants
Amini Tapouk et al. Antimicrobial Resistance and Infection Control           (2020) 9:115 Page 4 of 7
respectively. Figure 2 presents the median values of data
for disinfectants.
Discussion
Increased resistance of microorganisms to antibiotics
and disinfectants and emergence of biocide-resistant
bacterial strains have made it difficult to eliminate them.
Disinfectants are effective in reducing health care associ-
ated infections, but the correct choice of disinfectants
considering the wide range of efficacy against hospital
pathogens is important and essential in this process [15,
18]. The purpose of this study was to evaluate the effi-
cacy of three hospital disinfectants in two strains of
pathogenic bacteria based on MIC and MBC tests. Ac-
cording to Tables 2, 3, and Fig. 2 the disinfectants did
not have an equal efficacy in the tested strains and B.
cepacia showed more resistance to all tested disinfec-
tants compared to E.faecalis. It can be concluded that
the same disinfectants should not be used for all wards,
sections and places in healthcare settings. The results of
this study showed that under the same conditions, dif-
ferent disinfectants revealed various efficacies and di-
verse ranges of activity against different bacterial strains.
On the other hand, equal concentrations of disinfectants
in the same application situation may have different ef-
fects on different types of bacteria. Therefore, before
choosing and applying any disinfection in hospitals, it is
absolutely necessary to measure the MIC and MBC
values of daily used disinfectants against common life-
threatening bacterial agents or healthcare associated
infections.
MIC and MBC assay tests are tools to determine
the effectiveness of disinfectants against micro-
organisms and to determine the sensitivity of bacteria
in health care settings [19, 20]. If MIC and MBC
values of a disinfectant are small enough, bacterial
growth is inhibited at low concentrations of the disin-
fectant; in this case, the disinfectant is stronger, more
effective, and suitable. In this situation, if the disinfec-
tatnt is inexpensive (reasonable price), it is considered
the best one compared to others. MIC values are usu-
ally less than MBCs, because higher concentrations of
an antibacterial agent are needed for bactericidal ver-
sus bacteriostatic effects in most cases. MIC is the
lowest concertation that inhibits the growth of tested
bacteria, whereas MBC is usually a relatively higher
concentration of the disinfectant that kills the micro-
organism. According to our findings, MIC and MBC
of the two disinfectants were equal values in all ex-
periments; this could be due to the optimal antibac-
terial properties of these biocidal agents. The MIC
and MBC results of MQ showed that in the same
conditions, it has different antibacterial effects on
tested strains. MQ, at a concentration of MIC =
MBC = 70.31 mg/L, reduced the growth of B. cepacia
ATCC 10673 to 3-Log (99.9%), whereas a 3-Log re-
duction (99.9%) in growth occurred at MIC =MBC =
2.2 mg/L for E. faecalis ATCC 29212. Therefore, it
can be concluded that either E. faecalis ATCC 29212
is more susceptible than B. cepacia ATCC 10673 to
this disinfectant or the antibacterial effect of MQ is
weaker on the B. cepacia ATCC 10673. Lower sensi-
tivity of gram-negative versus gram-positive bacteria
is mostly attributed to differences in chemical com-
position of gram-negative and gram positive cell walls,
resulting in different bacteria behaviors against disin-
fectants. The cell wall of the gram-negative bacteria
contains an outer membrane [21] that partly prevents
the penetration of disinfectants and antibiotics into
the bacterium. Acquisition of certain types of
Fig. 2 Medians of tested disinfectants (Steranios 2%, DH and MQ) concentrations as MIC = MBC (mg/L) on B. cepacia ATCC 10673 and E. faecalis
ATCC 29212
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plasmids can make gram negative bacteria more re-
sistant to biocides because of the production of de-
toxifying enzymes [22]. In this study, B. cepacia
ATCC 10673 (gram negative) was more resistant to
disinfectants compared to E. faecalis ATCC 29212
(gram-positive), but the mechanism of resistance was
not investigated. Therfore, more detailed studies are
required to explore the mechanism of resistance of
the studied bacteria to these disinfectants.
E.faecalis showed a high sensitivity to Steranios 2%
(MIC =MBC = 0.31 mg/L). However, in the same condi-
tions, the lowest bacteriostatic and bactericidal concen-
tration of Steranios 2% for B. cepacia was 9.83 mg/L. It
was also observed that E.faecalis was less resistant to
lower concentrations of disinfectant. So, in hospital
wards where E.faecalis is prevalent, even low concentra-
tions of Steranios 2% can be applied for eradication of
this strain. This recommendation should be taken with
cautionbecause the rate of resistance to Steranios 2% in
other prevalent hospital-acquired pathogens should be
determined and considered as well. The major compo-
nents of Steranios 2% are glutaraldehydes, which are
used as high-level disinfectants in healthcare settings for
sterilizing medical instruments such as endoscopes,
lenses, rubber, plastic, etc. Glutaraldehyde has no corro-
sive properties and its shelf- life is 14 days [1]. It stimu-
lates the skin, eyes, and respiratory tract and there are
occasional health problems such as occupational asthma
in dealing with glutaraldehyde [23]. Therefore, when glu-
taraldehyde is used as a disinfectant, care should be
taken and attention should be paid to ventilation. The
range of bactericidal (MIC) or bacteriostatic concentra-
tions (MIC) of Steranios 2% was 5035–9.83 mg/L for B.
cepacia and 5035–0.31 mg/L for E.faecalis. Pariscila
et al. [11], showed that the MIC values of glutaraldehyde
for E. cloacae, B. subtilis and E. coli were in the range of
2750–3750 mg/L. Whereas, our results show that the
MIC values were markedly lower in the present study
(0.31 mg/L vs. 2750–3750 mg/L).
Another disinfectant in this study was DH whose ef-
fectiveness was compared with other tested disinfectants.
Its main ingredient is peracetic acid (PAA). Peracetic
acid is a suitable alternative for decontamination of
heat-sensitive medical equipment. This antibacterial
agent has a rapid activity against bacterial spores, but it
has corrosive effects on some metal equipment [24]. The
present study also showed (Table 3) that B. cepacia was
generally less sensitive to DH than E. faecalis. At 19.53
mg/L, DH showed marked antibacterial effects against E.
faecalis whereas B. cepacia was more tolerant to it. The
bactericidal concentration range of DH was 5000–
156.25 mg/L for B. cepacia and 5000–19.53 mg/L for E.
faecalis. So, it can be concluded that 19.53 mg/L of DH
has bactericidal effects on 99.9% of E. faecalis
population, but the same concentration is ineffective on
B. cepacia. In another study, the MIC range of peracetic
acid for B. cepacia and some gram-negative strains was
2310–4491 mg/L [19] which was in the scope of our
study. The median concentration of Sterniose 2% against
E. faecalis and B. cepacia was lower than DH and MQ,
respectively (Fig. 2). In addition E. faecalis needs a lower
bactericidal concentration range of disinfectants com-
pared to B. cepacia and a lower median of a disinfectant
is the most effective against pathogens.
MIC and MBC represent the minimum inhibitory
and minimum bactericidal concentration of disinfec-
tants at 24 h [25], However, to minimize the risk of
infection in hospital environments, there is a need for
a potent antibacterial activity in very shorter exposure
time for disinfection of critical equipment. Therefore,
future studies should be conducted to determine the
bacteriostatic and bactericidal effects of disinfectants
at short time exposures, including 5, 10, and 20 min.
Due to the limited number of critical items (e.g.
endoscopic instruments, bronchoscopes, arthroscopy
devices, etc.) in our hospital and the physicians’ inter-
est in visiting more patients in less time, it is recom-
mended to determine the effective concentrations of
various disinfectants (low, intermediate, and high
level) in short contact times with pathogenic microor-
ganisms. In this study, the bacteriostatic and bacteri-
cidal effects of three different disinfectants were
investigated on reference isolates of E. faecalis and B.
cepacia. It is obvious that bacterial isolates from pa-
tients, hospital personnel, or hospital environment are
usually more resistant to antimicrobial agents, so fur-
ther studies in a larger number of hospital isolates
are recommended. The present study showed the dif-
ferent efficacy of three classes of disinfectants on two
different strains of bacteria. Considering the variable
effects of disinfectants on several nosocomial patho-
gens, alternate use of disinfectants in hospital wards
is highly recommended. These findings could be used
in hospitals or health care settings where the efficacy
of disinfectants is important.
Conclusion
In conclusion the most effective surface and instrument
disinfectants against both E. faecalis and B. cepacia were
Steranios 2% (MIC = 0.31 mg/L) >MQ (MIC = 2.20 mg/
L) > DH (MIC = 9.77 mg/L) and Steranios 2% (MIC =
9.83 mg/L) >MQ (MIC = 70.31 mg/L) > DH (MIC =
78.13 mg/L), respectively. The use of non-lethal doses
(sub-MIC) of disinfectants not only does not stop the
growth of these pathogens but also increases the resist-
ance level of microorganisms to disinfectants. The use of
higher concentrations of disinfectants (above MBC) only
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results in overconsumption of disinfectants and is not
cost-effective.
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